At a recent life-sciences conference in Stockholm, execs of several U.S. and foreign biotechs clashed with Big Pharma in a lively debate on the merits of their respective goals and products. The result, however, was a stand-off.
Continue reading Inside Wall Street: Biotechs vs. Big Pharma in a Swedish Showdown
Inside Wall Street: Biotechs vs. Big Pharma in a Swedish Showdown originally appeared on DailyFinance on Mon, 18 Oct 2010 07:30:00.
Filed Under: Company News, Columns, Investing, Health Care, Pfizer, Bristol-Myers Squibb, Abbott, Stocks in the News